NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹131 Cr | ₹83 Cr | ₹90 Cr | ₹66 Cr | ₹64 Cr |
What is the latest Sundry Debtors ratio of NGL FINECHEM ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹131 Cr |
| Mar2025 | ₹83 Cr |
| Mar2024 | ₹90 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹64 Cr |
How is Sundry Debtors of NGL FINECHEM Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹131 Cr | 57.98 | |
| Mar2025 | ₹83 Cr | -7.56 | |
| Mar2024 | ₹90 Cr | 36.05 | |
| Mar2023 | ₹66 Cr | 2.96 | |
| Mar2022 | ₹64 Cr | - | |
Compare Sundry Debtors of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,651.2 Cr | -6.7% | -22.7% | 81.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -6.7% |
-22.7% |
81.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses